エピソード

  • Energy transitions, sharing vaccines, and making research accessible for non-English speakers
    2024/09/12

    In something of a bonus episode, Gavin, Richard, and Jessamy sit down for an informal chat about what's going on in the news, in health, and in the world of The Lancet, covering healthcare emissions, solar power, and the challenge of global co-operation on vaccines.

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    39 分
  • Health in Africa: Mpox and the Public Health Emergency of International Concern
    2024/09/06

    The mpox case surge in Africa has been declared a Public Health Emergency of International Concern (PHEIC) by the WHO. A new clade of the virus has emerged since the 2022 outbreak which has led to a rapid increase in cases. Professor Salim Abdool Karim, who is the the chair of the Africa CDC’s Emergency Consultative Group and the director of CAPRISA, the Center for the AIDS Programme of Research in South Africa, joins Gavin Cleaver and Maneet Virdi to lay out in clear terms what's happening in Africa, what the PHEIC means, and what the future could look like.

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    26 分
  • The UK's COVID-19 public enquiry, with Richard Horton
    2024/08/22

    The first module of the UK's COVID-19 enquiry was published in July 2024. The enquiry found that the UK prepared for the wrong sort of pandemic, suffered from groupthink, and ultimately failed its citizens, more than 200,000 of whom died as a result of the pandemic.

    Editor-in-chief of The Lancet, Richard Horton, joins Gavin and Jessamy to discuss his experiences giving evidence to the enquiry. We reflect on the findings, dissect their meaning for pandemic preparedness, and talk about what the UK government needs to do next.

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    43 分
  • Developments in our understanding of dementia
    2024/07/31

    14 modifiable risk factors account for 45% of dementia cases worldwide. Gavin and Jessamy are joined by Prof. Gill Livingston (UCL) and Prof. Geir Selbaek (University of Oslo) to discuss the 2024 updates to The Lancet Commission on dementia prevention.

    You can read the Commission here:
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0?dgcid=buzzsprout_tlv_podcast_generic_lancet

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    35 分
  • Losing progress on human rights
    2024/07/22

    Gavin and Jessamy are joined by Mandeep Dhaliwal, Director of UNDP’s HIV, Health and Development Group, to discuss the access to health and freedom of the most vulnerable people around the world. Are we maintaining progress on rights, or are we in danger of backsliding?

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    30 分
  • Ozempic, public health, and black markets
    2024/07/11

    Gavin and Jessamy are joined by Oksana Pyzik (UCL, Fight The Fakes Alliance) to discuss how Ozempic/Wegovy/semaglutide works, what becoming mainstream means for our understanding of obesity and public health, and how demand is fuelling an unregulated black market in the drugs.

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    40 分
  • Women in global health
    2024/06/13

    Anita Zaidi, President of The Gender Equality Division at the Gates Foundation, joins Gavin to discuss women in global health from visibility in data all the way through to women in leadership positions in global health. Also on the agenda is the impact of vaccines, innovations in gender equity, and challenges and successes in addressing maternal mortality.

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    24 分
  • AI and LLMs in healthcare
    2024/05/30

    Gavin and Jessamy are joined by Rupa Sarkar, editor-in-chief of The Lancet Digital Health, to discuss the uses of Large Language Models (LLMs) in healthcare, the safety and patient concerns, progress that’s been made, and the what the future of AI in health might hold.

    Send us your feedback!

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    続きを読む 一部表示
    32 分